Improvement in health-related quality of life with recombinant factor IX prophylaxis in severe or moderately severe haemophilia B patients: results from the BAX326 Pivotal Study.

Abstract

Little is known about the health-related quality of life (HRQoL) burden of haemophilia B. The aim of this study was to assess HRQoL burden of haemophilia B, the benefit of recombinant factor IX (rFIX) prophylaxis and the HRQoL benefit of achieving a zero annual bleed rate. Subjects receiving rFIX (BAX326) prophylaxis or on-demand completed the SF-36 survey… (More)
DOI: 10.1111/hae.12315

Topics

Cite this paper

@article{Windyga2014ImprovementIH, title={Improvement in health-related quality of life with recombinant factor IX prophylaxis in severe or moderately severe haemophilia B patients: results from the BAX326 Pivotal Study.}, author={J Windyga and Vincent W. J. Lin and J D Epstein and Diane Ito and Y M Xiong and Brigitt E Abbuehl and Jorge Ram{\'i}rez}, journal={Haemophilia : the official journal of the World Federation of Hemophilia}, year={2014}, volume={20 3}, pages={362-8} }